Erratum to “Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD” [World Allergy Organ (2023) 100817]
Main Authors: | Fatma Merve Tepetam, MD, Şeyma Özden, MD, Fatma Kübra Kılıç, MD, Cihan Örçen, MD, Tuğçe Yakut, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455123001229 |
Similar Items
-
Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD
by: Fatma Merve Tepetam, MD, et al.
Published: (2023-09-01) -
Critical pathomechanisms of NSAID-exacerbated respiratory disease (N-ERD) clarified by treatment with omalizumab, an anti-IgE antibody
by: Hiroaki Hayashi, et al.
Published: (2025-01-01) -
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
by: Dorien Van Broeck, et al.
Published: (2023-04-01) -
Erdély jogtörténete
by: Sándor Nyiri
Published: (2018-11-01) -
Klimageschichte Der Erde
Published: (1969-01-01)